Table 1.
Baseline characteristics of the studied population, divided into a seniors group and a comparison group of younger individuals.
| Variable | Study group (seniors) n = 182 | Reference group (younger individuals) n = 45 | Significance of the difference |
|---|---|---|---|
| Age (years) | 79 (77–82) | 46 (36–60) | P < 0.0001 |
| Sex (females) | 126 (69%) | 29 (64%) | P = 0.537 |
| Statin treatment | 78 (43%) | 5 (11%) | P = 0.0001 |
| suPAR (ng/mL) | 3.79 (3.17–4.52) | 3.16 (2.65–3.51) | P < 0.0001 |
| TC (mmol/L) | 5.46 (4.66–6.35) | 5.41 (4.92–5.84) | P = 0.617 |
| HDL-C (mmol/L) | 1.63 (1.35–1.93) | 1.45 (1.28–1.72) | P = 0.011 |
| LDL-C (mmol/L) | 3.21 (2.40–3.93) | 3.63 (2.85–4.50) | P = 0.005 |
| TG (mmol/L) | 1.31 (1.03–1.63) | 1.35 (0.99–1.97) | P = 0.421 |
| HbA1c (%) | 5.6 (5.3–5.9) | 5.0 (4.8–5.2) | P < 0.0001 |
| CREA (µmol/L) | 75 (82–104) | 85 (74–95) | P = 0.004 |
| eGFR CKD-EPI (mL/min/1.73m2) | 73 (61–81) | 77 (71–92) | P < 0.0001 |
| CRP-hs (mg/L) | 1.61 (0.95–2.94) | 1.10 (0.52–2.21) | P = 0.003 |
| TnT-hs (ng/L) | 9.3 (8.3–10.1) | 5.5 (4.6–6.5) | P < 0.0001 |
| NT-proBNP (pg/mL) | 212 (108–420) | 29 (20–42) | P < 0.0001 |
The variables are expressed as median and interquartile range.